Coordinators

Other Contributors

About Us

www.clpblog.org

The contributors to the Consumer Law & Policy blog are lawyers and law professors who practice, teach, or write about consumer law and policy. The blog is hosted by Public Citizen Litigation Group, but the views expressed here are solely those of the individual contributors (and don't necessarily reflect the views of institutions with which they are affiliated). To view the blog's policies, please click here.

« Supreme Court grants review in Noel Canning recess-appointment case | Main | Will Banks Get Out of the Deposit Advance Loan Business? If So, Is That Desirable? »

Monday, June 24, 2013

Comments

Ronen

" If you (the patient) happen to have been prescribed a brand-name drug and that drug injures you, your suit can go forward; if you were prescribed the brand-name drug's generic copy -- which public policy has favored for three decades -- your suit against the generic manufacturer is kaput. Got that?"

Well - the idea is that the generic manufacturer has no freedom (and thus - cannot err) in labeling its product. FDA requires the label to be identical to that of the original drug. It does make perfect sense.

The comments to this entry are closed.

Subscribe to CL&P

RSS/Atom Feed

To receive a daily email of Consumer Law & Policy content, enter your email address here:

Search CL&P Blog

Recent Posts

January 2020

Sun Mon Tue Wed Thu Fri Sat
      1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31